Literature DB >> 31372600

Corneal Neuropathy: An Underrated Manifestation of Diabetes Mellitus.

Arpine Barsegian1, Justin Lee2, Moro O Salifu2, Samy I McFarlane2.   

Abstract

Diabetes Mellitus (DM) is widely recognized as a major cause of blindness, with Diabetic Retinopathy (DR) being the most frequently cited underlying pathophysiologic mechanism. This makes DR, among all ocular manifestations of diabetes, the focus of most diagnostic as well as therapeutic interventions. However, diabetic neurotrophic keratopathy, a common ocular complication of diabetes that is caused by corneal nerve fiber damage, is a diagnostic entity that generated a lot of attention recently in the ophthalmology community for being largely unrecognized, underdiagnosed and generally not treated, rendering a large number of the growing population susceptible to this serious ocular complication. This is largely because of the challenge in diagnosis and management of diabetic neurotrophic keratopathy. In this manuscript, we discuss the epidemiology, pathophysiologic mechanisms, diagnostic challenges and the innovative therapeutic interventions of diabetic neurotrophic keratopathy, an entity with potentially serious implications for diabetic patients, both type 1 as well as type 2 alike.

Entities:  

Year:  2018        PMID: 31372600      PMCID: PMC6671630     

Source DB:  PubMed          Journal:  J Clin Endocrinol Diabetes


  9 in total

Review 1.  Complications in Retinal Surgery: A Review of Corneal Changes Following Vitreoretinal Procedures.

Authors:  Paula A Sepulveda-Beltran; Harry Levine; Victoria S Chang; Allister Gibbons; Jaime D Martinez
Journal:  Int Ophthalmol Clin       Date:  2022-06-22

2.  Effectiveness of 0.15% hylan A eye drops in ameliorating symptoms of severe dry eye patients in Saudi Arabia.

Authors:  Osama Alsheikh; Sultan Alzaaidi; Jose M Vargas; Eman Al-Sharif; Mohammed Alrajeh; Mohammad A AlSemari; Abdulrahman Alhommadi; Anoud Alsaati; Nouf Aljwaiser; Eman Alshahwan; Mona Abdulhafiz; Rashad Elsayed; Wolfgang G K Müller-Lierheim
Journal:  Saudi J Ophthalmol       Date:  2022-06-13

Review 3.  The impact of sensory neuropathy and inflammation on epithelial wound healing in diabetic corneas.

Authors:  Fu-Shin X Yu; Patrick S Y Lee; Lingling Yang; Nan Gao; Yangyang Zhang; Alexander V Ljubimov; Ellen Yang; Qingjun Zhou; Lixin Xie
Journal:  Prog Retin Eye Res       Date:  2022-01-04       Impact factor: 19.704

Review 4.  Diabetic keratopathy: Insights and challenges.

Authors:  S Priyadarsini; A Whelchel; S Nicholas; R Sharif; K Riaz; D Karamichos
Journal:  Surv Ophthalmol       Date:  2020-02-22       Impact factor: 6.048

Review 5.  Systemic diseases and the cornea.

Authors:  Ruchi Shah; Cynthia Amador; Kati Tormanen; Sean Ghiam; Mehrnoosh Saghizadeh; Vaithi Arumugaswami; Ashok Kumar; Andrei A Kramerov; Alexander V Ljubimov
Journal:  Exp Eye Res       Date:  2021-01-21       Impact factor: 3.467

Review 6.  Diabetic Corneal Neuropathy.

Authors:  Hassan Mansoor; Hong Chang Tan; Molly Tzu-Yu Lin; Jodhbir S Mehta; Yu-Chi Liu
Journal:  J Clin Med       Date:  2020-12-06       Impact factor: 4.241

7.  High Molecular Weight Hyaluronan Promotes Corneal Nerve Growth in Severe Dry Eyes.

Authors:  Gysbert-Botho van Setten; Oliver Stachs; Bénédicte Dupas; Semra Akkaya Turhan; Berthold Seitz; Herbert Reitsamer; Karsten Winter; Jutta Horwath-Winter; Rudolf F Guthoff; Wolfgang G K Müller-Lierheim
Journal:  J Clin Med       Date:  2020-11-24       Impact factor: 4.241

Review 8.  Diabetic Corneal Neuropathy: Pathogenic Mechanisms and Therapeutic Strategies.

Authors:  Ting Zhou; Allie Lee; Amy Cheuk Yin Lo; Jeremy Sze Wai John Kwok
Journal:  Front Pharmacol       Date:  2022-02-23       Impact factor: 5.810

9.  Pathogenic Role of Diabetes-Induced Overexpression of Kallistatin in Corneal Wound Healing Deficiency Through Inhibition of Canonical Wnt Signaling.

Authors:  Wentao Liang; Li Huang; Xiang Ma; Lijie Dong; Rui Cheng; Marcus Dehdarani; Dimitrios Karamichos; Jian-Xing Ma
Journal:  Diabetes       Date:  2022-04-01       Impact factor: 9.461

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.